Stem cell sources for cell-based therapeutics are often screened for infectious agents and genetic diseases prior to implantation; however, there are other risk factors that are often overlooked, which may ultimately lead to less efficacious clinical outcomes

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Alleviating-Neuropathic-Scar-Pain-Jan-2018.pdf” title=”PRP in Alleviating Neuropathic Scar Pain Jan 2018″]